Cancer, genomics and personalised medicine: Modelling the future of oncology
pharmaphorum
JANUARY 29, 2019
The prevalence of cancer is currently predicted to be higher than ever. Current statistics show 1 in 2 people in the UK and 1 in 2 men/1 in 3 women in the US will experience it at some stage in their lives. And yet the picture for patients is an improving one. The move towards immunotherapies heralds much promise and this is potentially just the beginning.
Let's personalize your content